Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA7 | P43166 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18741353 | 0.89 | KMT2A (0.47) | CA1CA2CA7CA9CA12 | |
| SCHEMBL9319281 | 0.85 | CA1 (0.55) | CA1CA2CA7CA9CA12 | |
| SCHEMBL14473616 | 0.82 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL10713299 | 0.82 | RAB9A (0.52) | TDP1MAPK1ALDH1A1TSHRACHE | |
| SCHEMBL10642557 | 0.82 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1975657 | 0.82 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL11749098 | 0.81 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL45199 | 0.81 | MEN1 (0.41) | TDP1MAPK1ALDH1A1TSHRALOX15 | |
| SCHEMBL1782247 | 0.81 | CYP2A6 (0.52) | MAPK1NPC1RAB9AKDM4EMEN1 | |
| SCHEMBL3799108 | 0.80 | CA1 (0.55) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306166-A2 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Aquinnah Pharmaceuticals Inc. (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20230303489-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | AQUINNAH PHARMACEUTICALS INC (US) | 2023-09-28 | — | — | US | disclosed |
| US-20230303489-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | AQUINNAH PHARMACEUTICALS INC (US) | 2023-09-28 | — | — | US | disclosed |
| EP-3557998-B1 | COMPOUNS, COMPOSITIONS AND METHODS OF USE | AQUINNAH PHARMACEUTICALS INC (US) | 2023-08-16 | — | — | EP | disclosed |
| US-11542233-B2 | Compounds, compositions and methods of use | AQUINNAH PHARMACEUTICALS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-10766982-B2 | Cationic polymerization of olefins using green acids | LEWIS STEWART P (US) | 2020-09-08 | — | — | US | disclosed |
| US-20200270211-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | AQUINNAH PHARMACEUTICALS INC (US) | 2020-08-27 | — | — | US | disclosed |
| US-20190330395-A1 | CATIONIC POLYMERIZATION OF OLEFINS USING GREEN ACIDS | LEWIS STEWART P (US) | 2019-10-31 | — | — | US | disclosed |
| US-20180305334-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES | AQUINNAH PHARMACEUTICALS, INC. | 2018-10-25 | — | — | US | disclosed |
| WO-2018119395-A1 | COMPOUNS, COMPOSITIONS AND METHODS OF USE | AQUINNAH PHARMACEUTICALS, INC. (US) | 2018-06-28 | — | — | WO | disclosed |
| US-20060135711-A1 | Process for the production of living radical polymers and polymers | OTSUKA CHEMICAL CO., LTD. (JP) | 2006-06-22 | — | — | US | disclosed |
| CN-1780860-A | Method for producing living radical polymer and polymer | OTSUKA CHEMICAL CO LTD (JP) | 2006-05-31 | — | — | CN | disclosed |
| EP-1619211-A1 | PROCESS FOR PRODUCTION OF LIVING-RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2006-01-25 | — | — | EP | disclosed |
| EP-1595894-A1 | PROCESS FOR THE PRODUCTION OF LIVING RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2005-11-16 | — | — | EP | disclosed |
| US-20050245714-A1 | Organic tellurium compound, process for producing the same, living radical polymerization initiator, process for producing polymer with the same, and polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2005-11-03 | — | — | US | disclosed |
| CN-1675253-A | Method for producing living radical polymer and polymer | OTSUKA CHEMICAL CO LTD (JP) | 2005-09-28 | — | — | CN | disclosed |
| CN-1649838-A | Organic tellurium compound, method for producing same, living radical polymerization initiator, method for producing polymer using same, and polymer | OTSUKA KAGAKU KK (JP) | 2005-08-03 | — | — | CN | disclosed |
| EP-1541550-A1 | ORGANIC TELLURIUM COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH THE SAME, AND POLYMER | Otsuka Chemical Co., Ltd. (JP) | 2005-06-15 | — | — | EP | disclosed |
| EP-1541592-A1 | PROCESS FOR PRODUCTION OF LIVING RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2005-06-15 | — | — | EP | disclosed |
| US-4130577-A | FROM THE HALIDE AND AN ALKALI METAL CYANATE | SHOWA DENKO K.K. (JP) | 1978-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542233-B2 | Compounds, compositions and methods of use | FUS, TFEB, CLN6 | CA1 4206/4885CA2 3676/4885CA7 3620/4885 |
| US-20050245714-A1 | Organic tellurium compound, process for producing the same, living radical polymerization initiator, process for producing polymer with the same, and polymer | ODC1, TERB1, TTI1 | CA1 1190/4885CA2 1325/4885CA7 577/4885 |
| US-20200270211-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | FUS, TFEB, CLN6 | CA1 4206/4885CA2 3676/4885CA7 3620/4885 |
| US-20230303489-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | FUS, TFEB, CLN6 | CA1 4206/4885CA2 3676/4885CA7 3620/4885 |
| US-20060135711-A1 | Process for the production of living radical polymers and polymers | CBR3, CBR1, CCNT1 | CA1 3016/4885CA2 2250/4885CA7 939/4885 |
| US-20180305334-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES | TIA1, FUS, GRN | CA1 4450/4885CA2 3739/4885CA7 4195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.